by | PRNewswire Asia
Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix®) for prostate cancer imaging in Japan. The study data will be used to support a New Drug Application (NDA) for TLX591-Px in Japan. MELBOURNE, Australia and TOKYO, July 17,...
by | PRNewswire Asia
Peer-reviewed preclinical findings validate the regenerative mechanism of HILO WAVE®’s proprietary Dual-HA Technology (DHC®). SEOUL, South Korea, July 16, 2026 /PRNewswire/ — HILO WAVE®, HIGHER Corporation’s proprietary Dual-HA Collagen...
by | PRNewswire Asia
SINGAPORE, July 16, 2026 /PRNewswire/ — Thermomix® is bringing its first-ever Thermomix® TasteMaster Cook-Off 2026 to Singapore, a culinary competition celebrating everyday Singaporeans and the personal stories behind the dishes they love. From treasured...
by | PRNewswire Asia
HAIKOU, China, July 16, 2026 /PRNewswire/ — China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced that, in view of the unusual...
by | PRNewswire Asia
Key Highlights: Yaumati Catholic Primary School (Hoi Wang Road) successfully defends its title, winning the FLL Challenge Primary School Division Champion for the second consecutive year Australian International School Hong Kong claims the FLL Challenge Secondary...
by | PRNewswire Asia
Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to support the company’s next phase of growth Bambusa also forms a Scientific Advisory Board of globally recognized leaders in biopharma, dermatology, and respiratory medicine to...
